These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23863609)

  • 1. Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon conference 2013.
    Maitra A; Bhakta S
    Virulence; 2013 Aug; 4(6):499-503. PubMed ID: 23863609
    [No Abstract]   [Full Text] [Related]  

  • 2. Could Killing Bacterial Subpopulations Hit Tuberculosis out of the Park?
    Baranowski C; Rubin EJ
    J Med Chem; 2016 Jul; 59(13):6025-6. PubMed ID: 27322073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
    Sacchettini JC; Rubin EJ; Freundlich JS
    Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of persisters in tuberculosis drug discovery.
    Mandal S; Njikan S; Kumar A; Early JV; Parish T
    Microbiology (Reading); 2019 May; 165(5):492-499. PubMed ID: 30775961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis drug resistance mutation database.
    Sandgren A; Strong M; Muthukrishnan P; Weiner BK; Church GM; Murray MB
    PLoS Med; 2009 Feb; 6(2):e2. PubMed ID: 19209951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
    Islam MM; Hameed HMA; Mugweru J; Chhotaray C; Wang C; Tan Y; Liu J; Li X; Tan S; Ojima I; Yew WW; Nuermberger E; Lamichhane G; Zhang T
    J Genet Genomics; 2017 Jan; 44(1):21-37. PubMed ID: 28117224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new anti-tuberculosis drug candidates.
    Shi R; Sugawara I
    Tohoku J Exp Med; 2010 Jun; 221(2):97-106. PubMed ID: 20467231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid activity is terminated by bacterial persistence.
    Mitchison DA; Jindani A; Davies GR; Sirgel F
    J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS; Rather MA; Maqbool M; Ahmad Z
    Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence, not resistance, is the cause of loss of isoniazid effect.
    Wallis RS; Palaci M; Eisenach K
    J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
    [No Abstract]   [Full Text] [Related]  

  • 12. New drugs for the treatment of Mycobacterium tuberculosis infection.
    AlMatar M; AlMandeal H; Var I; Kayar B; Köksal F
    Biomed Pharmacother; 2017 Jul; 91():546-558. PubMed ID: 28482292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling tuberculosis: Insights from an international TB Summit in London.
    Maitra A; Danquah CA; Scotti F; Howard TK; Kamil TK; Bhakta S
    Virulence; 2015; 6(6):661-72. PubMed ID: 26151309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-directed drug therapy for tuberculosis.
    Guler R; Brombacher F
    Nat Chem Biol; 2015 Oct; 11(10):748-51. PubMed ID: 26379013
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel and revisited approaches in antituberculosis drug discovery.
    Herrmann J; Rybniker J; Müller R
    Curr Opin Biotechnol; 2017 Dec; 48():94-101. PubMed ID: 28427007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis].
    Blaas S
    Dtsch Med Wochenschr; 2017 Dec; 142(24):1838-1842. PubMed ID: 28898913
    [No Abstract]   [Full Text] [Related]  

  • 18. Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents.
    Evans JC; Mizrahi V
    Curr Opin Microbiol; 2018 Oct; 45():39-46. PubMed ID: 29482115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.
    Geadas C; Stoszek SK; Sherman D; Andrade BB; Srinivasan S; Hamilton CD; Ellner J
    Tuberculosis (Edinb); 2017 Jan; 102():55-67. PubMed ID: 28061953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicine. New TB drug promises shorter, simpler treatment.
    Cohen J
    Science; 2004 Dec; 306(5703):1872. PubMed ID: 15591168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.